Site navigation

Navigation

Lung cancer (non-small-cell) - pemetrexed

Pemetrexed for the treatment of non-small-cell lung cancer

Summary

  • Pemetrexed is not recommended for the treatment of locally advanced or metastatic non-small-cell lung cancer.
  • People currently receiving pemetrexed should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

Guidance documents

Implementing this guidance

We will consult on our review plans for this guidance in January 2010

About this guidance

Technology appraisals TA124

Issued: August 2007

See related guidance:

Order printed copies of this guidance